ERNA
Ernexa Therapeutics
$3.92
−$0.01 (−0.25%)Jul 27, 2026
Key metrics
The numbers that frame ERNA today
- Market cap
- $4.57M
- P/E (TTM)
- -0.4
- EV / FCF
- 0.6
- ROIC
- 1,216.9%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.18
- 52wk High
- $71.50
Growth
Revenue and earnings trend for ERNA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ERNA
Is Ernexa Therapeutics a good buy?
No. Ernexa Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of ERNA?
Ernexa Therapeutics's market capitalization is $4.57M.
What is the P/E ratio for ERNA stock?
Ernexa Therapeutics's current P/E ratio is -0.4.
What is the 52-week high for ERNA stock?
The 52-week high for Ernexa Therapeutics is $71.50. The current close of $3.92 is 94.5% below that high.
What is the 52-week low for ERNA stock?
The 52-week low for Ernexa Therapeutics is $3.18. The current close of $3.92 is 23.2% above that low.
Does ERNA stock pay dividends?
Ernexa Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ERNA?
Ernexa Therapeutics's Debt / Equity ratio is 0.06.